Mubadala Investment Company has acquired an 80% stake in Global Medical Supply Chain (GMSC) and Al Ittihad Drug Store (IDS) from GlobalOne Healthcare Holding (GHH). GHH will retain a 20% stake in the two companies.
This acquisition strengthens Mubadala’s presence in healthcare logistics and pharmaceutical distribution, aligning with the UAE’s strategy to develop a robust life sciences infrastructure.
Founded in 2015, GMSC provides supply chain services for medical products, including demand planning, procurement, logistics, inventory management, warehousing, and maintenance. GMSC supports over 200 medical facilities, including hospitals and clinics across the UAE, sourcing products from nearly 400 suppliers.
IDS, established in 1987, is a leading pharmaceutical and consumer healthcare product distributor in the UAE. The company distributes over 1,000 products from 40 suppliers to hospitals, pharmacies, and supermarkets nationwide, covering multiple therapeutic categories such as anti-infectives, asthma, diabetes, and oncology.
Ismail Ali Abdulla, Executive Director of UAE Clusters at Mubadala’s UAE Investments Platform, stated, “The expanding pharmaceutical market drives an increasing demand for specialised and efficient drug logistics solutions. By integrating GMSC and IDS into our portfolio, we are poised to create a vertically integrated life sciences sector in the UAE and enable its potential to encompass the entire value chain from logistics and distribution to specialised manufacturing.”
Low Ping, Group CEO of Yas Holding, added, “This transaction continues Mubadala’s strategic growth, following another significant acquisition by its new speciality pharmaceutical business, KELIX bio, which recently acquired a 100% stake in four pharma assets from GlobalOne Healthcare Holding’s, the healthcare division of Yas Holding. These concerted efforts underline Mubadala’s commitment to strengthening the UAE’s healthcare and pharmaceutical sectors as part of broader national ambitions for drug security and economic diversification.”
GlobalOne Healthcare Holding LLC, the healthcare division of Yas Holding, focuses on improving healthcare outcomes through investments in innovative healthcare solutions.